LUCAS TRIEMSTRA: Open Payments
NPI 1083952998 · HOLLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 31 payments from 7 companies in 2025. Trend: 2023 $422 · 2024 $444 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $314 |
| Ipsen Biopharmaceuticals, Inc | 3 | $148 |
| Boston Scientific Corporation | 1 | $113 |
| Madrigal Pharmaceuticals | 3 | $68 |
| ABBVIE INC. | 2 | $53 |
| Ardelyx, Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: XIFAXAN, IQIRVO, EXALT Model D, REZDIFFRA, RINVOQ, IBSRELA, ZENPEP.
Industry payments across MI — which companies pay providers there.
